{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/epistaxis-nosebleeds/background-information/causes/","result":{"pageContext":{"chapter":{"id":"05e8d25d-b629-5896-847e-76ab44c33576","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field 6eaab8b0-6828-4c75-9246-96c1e14436f4 --><h2>What causes it?</h2><!-- end field 6eaab8b0-6828-4c75-9246-96c1e14436f4 -->","summary":"","htmlStringContent":"<!-- begin item 233fcbeb-1f68-4a94-9908-dc243eab0b76 --><!-- begin field f46dbaa8-d418-41bf-b5df-e54beb4712db --><ul><li><strong>Blood vessels inside the nose are superficial and easily damaged, particularly in Little's area where numerous arteries anastomose to form 'Kiesselbach’s plexus' under the thin overlying nasal mucosa.</strong> Most epistaxis is self-limiting and harmless, and the cause of damage to the blood vessels is not identified.</li><li><strong>Local causes of damage </strong><strong>to the blood vessels may include:</strong><ul><li>Trauma — injury from nose-picking, nasal fractures, septal ulcers or perforations, foreign body, or blunt trauma (such as falls in children).</li><li>Inflammation — infection (for example chronic sinusitis), allergic rhinosinusitis, or nasal polyps.</li><li>Topical drugs — for example cocaine, decongestants, or corticosteroids.</li><li>Vascular causes — for example hereditary haemorrhagic telangiectasia or Wegener's granulomatosis.</li><li>Post-operative bleeding — for example following ear, nose, and throat surgery; maxillofacial surgery; or ophthalmic surgery.</li><li>Tumours — benign (such as angiofibroma — a rare nasopharnygeal tumour largely affecting adolescent males) or malignant (such as squamous cell carcinoma — more likely in older people) </li><li>Nasal oxygen therapy — causes drying of the nasal mucosa and possible direct mucosal trauma via prongs of cannulae.</li></ul></li><li><strong>More general causes of damage may </strong><strong>include:</strong><ul><li>Atherosclerosis.</li><li>Increased venous pressure from mitral stenosis.</li><li>Haematological conditions affecting clotting — such as thrombocytopenia, platelet dysfunction, Von Willebrand disease, leukaemia, and haemophilia.</li><li>Environmental factors — temperature, humidity, altitude, exposure to irritants such as dust, certain chemicals, and cigarette smoke.</li><li>Systemic drugs — including anticoagulants and antiplatelet drugs (for example aspirin and clopidogrel).</li><li>Excessive alcohol consumption.</li></ul></li><li><strong>Hypertension is common in people who present with epistaxis; however, there is insufficient evidence to establish a causal relationship:</strong><ul><li>The reported prevalence of hypertension in people with epistaxis is up to to 64%.</li><li>A meta-analysis of ten studies concluded that people with hypertension had a statistically-significant up to 50% increased risk of epistaxis compared to people without hypertension.</li><li>However, the authors concluded that the presence of high arterial blood pressure during acute epistaxis cannot prove causation. This is at least partly because of the potential confounding effects of stress caused by the bleeding episode [<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Min et al, 2017</a>].</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Pashen and Stevens, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Wormald, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Crown and Criner, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kucik and Clenney, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Pope and Hobbs, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Schlosser, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Kasperek and Pollock, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">McGarry, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">Patel and Fowell, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/epistaxis-nosebleeds/references/\">BMJ Best Practice, 2018</a>]</p><!-- end field f46dbaa8-d418-41bf-b5df-e54beb4712db --><!-- end item 233fcbeb-1f68-4a94-9908-dc243eab0b76 -->","topic":{"id":"41f6c6fa-463d-5a28-9ffa-15f68320f0ad","topicId":"4e494407-5d2a-47b0-8980-124980c278b3","topicName":"Epistaxis (nosebleeds)","slug":"epistaxis-nosebleeds","lastRevised":"Last revised in August 2020","chapters":[{"id":"8924b1cb-1830-5e93-a601-5a515e1ef05c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"7267ef2e-a210-5137-a813-dac8e91b1831","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b0e06988-22ae-5f73-bb20-2033460ee20a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fb00e926-a8d3-5ae8-8f15-5dca94fff64d","slug":"changes","fullItemName":"Changes"},{"id":"a4dfa534-2e88-5962-97a7-50f5bc6903c5","slug":"update","fullItemName":"Update"}]},{"id":"182f787a-708c-5014-9591-48eddb54268d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bcaf0313-1bdc-548f-971f-dc9159fb2738","slug":"goals","fullItemName":"Goals"},{"id":"1820dda9-b7b1-5247-ad00-826f0b3f4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6508b703-ccd2-56fe-b323-3dfd267f6057","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"27ddc66a-0532-592f-be80-40b6581b9e9c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d6beda29-ddc7-569c-8f25-2395cd0b3213","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9b9f6fbd-0722-5dcc-afac-e879fdfc6832","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1c7c7c7b-4f02-5cb0-af91-12ff20526fa7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6a3ef102-679b-5a9e-9d3d-73b58b70d2ef","slug":"definition","fullItemName":"Definition"},{"id":"05e8d25d-b629-5896-847e-76ab44c33576","slug":"causes","fullItemName":"Causes"},{"id":"7e0e17b8-b890-541e-92b5-0790ae3d08b5","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2624ce06-f85b-541e-a7bb-589ee1197b08","slug":"prognosis","fullItemName":"Prognosis"},{"id":"7f96f0b5-4a51-5413-b0b1-73ea61f581ac","slug":"complications","fullItemName":"Complications"}]},{"id":"eee7ea0d-538e-53b8-bf4c-3333153a7978","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4ac070a5-a9e9-58a1-a125-c8a457f1833a","slug":"assessment","fullItemName":"Assessment"}]},{"id":"662dfd0d-d907-52ea-8d8b-97a3cf464cc7","fullItemName":"Management","slug":"management","subChapters":[{"id":"e0220daa-0b07-5f92-af4d-9530f90352ea","slug":"acute-epistaxis","fullItemName":"Scenario: Acute epistaxis"},{"id":"49c8979b-9af3-5eab-a574-05004fda4a4a","slug":"recurrent-epistaxis","fullItemName":"Scenario: Recurrent epistaxis"}]},{"id":"91147d78-80c8-5364-b3e1-7995b6718b2a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c7a65cbb-e7c2-50f8-b6a2-68a41e1db4cb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bb7e51c5-d888-5640-8c0b-07c8a505bf48","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3c48404f-ce42-5815-8d02-6dd6ef1ae5f3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b82f78a8-0e22-5156-bc34-baaa9c78ee15","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6093800a-eb2a-53e5-918a-e8f0be8c4ae0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6ce6588e-beaa-5a3b-a424-cfad9a225022","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1343761f-c431-50df-9bd2-a9b600c5e067","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1c7c7c7b-4f02-5cb0-af91-12ff20526fa7","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}